Log in to save to my catalogue

Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infan...

Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2645707709

Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements

About this item

Full title

Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements

Publisher

London: Nature Publishing

Journal title

Leukemia, 2005-02, Vol.19 (2), p.214-216

Language

English

Formats

Publication information

Publisher

London: Nature Publishing

More information

Scope and Contents

Contents

NAD(P)H:quinone oxidoreductase 1 (NQO1) is a detoxification enzyme that protects cells against oxidative stress and toxic quinones. A polymorphism (C609T) in the gene produces in the heterozygous individuals (C/T) a reduction and in those homozygous for the variant allele (T/T) the abolishment of NQO1 protein activity. To assess whether NQO1 inacti...

Alternative Titles

Full title

Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2645707709

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2645707709

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/sj.leu.2403613

How to access this item